As previously described in CAFs, we also observed AR binding in functional enhancer regions that are marked by the H3K27Ac acetylation mark and very limited overlap of AR sites was observed between fibroblasts, prostate tumors, and LNCaP (Nash et al., 2017; Nevedomskaya et al., 2016). Here, AR is linked to prostate neoplasm.